EQT Completes Azelis Exit in €190M Deal, Capping a Seven-Year Saga

By Daniel Thomas

STOCKHOLM, SWEDEN – February 27, 2026 – Private equity firm EQT has officially closed the book on its highly successful investment in Azelis Group NV, completing the sale of its final 10% stake in the specialty chemicals distributor for approximately €190 million.

The final transaction, which saw the EQT VIII fund receive gross proceeds of around €173 million, marks the culmination of a seven-year journey that transformed Azelis from a private-equity-owned entity into a major independent public company. The selldown of roughly 24 million shares was managed by a syndicate of banks including Goldman Sachs International, J.P. Morgan SE, and BNP PARIBAS, concluding a multi-stage exit strategy that has been closely watched by the market.

This final move liquidates EQT's position, which began with a majority stake acquisition in November 2018. Under EQT's stewardship, Azelis has undergone a significant expansion, solidifying its position as a global innovation service provider for the specialty chemicals and food ingredients industries.

A Masterclass in Value Creation

EQT's tenure is a case study in modern private equity value creation. After acquiring Azelis from Apax Partners in a deal reportedly valued at over €2 billion, EQT embarked on an ambitious growth strategy. This strategy was not merely financial engineering but a fundamental reshaping of the business through a combination of organic growth, aggressive bolt-on acquisitions, and operational improvements.

During this period, Azelis significantly expanded its geographic footprint and its network of application laboratories, which are crucial for helping its 65,000+ customers develop and refine product formulations. The company's top-line and EBITA figures saw substantial expansion, a testament to the success of the 'buy-and-build' strategy.

A pivotal moment in this journey was the company's Initial Public Offering (IPO) in September 2021. Azelis listed on the Brussels stock exchange at €26 per share, achieving a valuation of €6.1 billion and raising €1.77 billion. This event provided the first major liquidity opportunity for EQT and its co-investors, setting the stage for a gradual, structured exit over the following years through a series of partial selldowns in 2023 and 2025, leading to this week's final sale.

Azelis Charts an Independent Course

With EQT now fully out of the picture, Azelis stands as a fully independent public company, facing both significant opportunities and the headwinds of what its own management calls a "challenging chemicals market environment."

The company's most recent financial results reflect this reality. For the full year 2025, Azelis reported a slight decline in revenue to €4.13 billion from €4.24 billion in 2024, with net income falling to €111.19 million from €180.69 million. The fourth quarter was particularly tough, with a 23% year-on-year drop in adjusted EBITA, driven by what the company described as "broad end-market weakness."

Despite the market turbulence, Azelis's strategy for navigating the future is clear, resting on three core pillars: innovation, digitalization, and sustainability. The company continues to invest heavily in its digital platforms, including a Customer Portal and a sophisticated 'e-Lab' that allows clients to access technical expertise and co-develop formulations virtually. This digital-first approach is designed to create a differentiated customer experience and drive efficiency.

Furthermore, Azelis maintains a strong commitment to sustainability, holding an EcoVadis Gold rating. This focus is not just a matter of corporate responsibility but a strategic imperative in a specialty chemicals market increasingly driven by demand for green and sustainable materials, from electric vehicle battery chemistry to biodegradable ingredients.

Market Volatility and Investor Outlook

The market's reaction to Azelis's recent journey has been a mix of caution and optimism. Following the weaker-than-expected Q4 2025 results, the company's shares initially fell before rebounding, suggesting investors had already priced in the market weakness. The announcement of EQT's final selldown on February 26 was executed at €7.85 per share, a 6.1% discount to the prior closing price. However, news of the impending exit had actually caused the stock to rise earlier in the week, as the removal of a large, motivated seller is often seen as a positive for share price stability.

As of February 28, Azelis's stock closed at €8.40, still well below its €26 IPO price, with a market capitalization of around $2.38 billion. This has led some analysts to view the company as significantly undervalued. The consensus price target from analysts covering the stock is €19.56, with some suggesting a fair value closer to €13.20, implying a substantial potential upside from its current trading level. The departure of EQT, while marking the end of an era, provides clarity to the shareholder base and places the company's destiny firmly in the hands of its management and public investors.

Private Equity's Enduring Impact on Chemical Distribution

The EQT-Azelis saga is emblematic of a broader trend in the specialty chemicals distribution sector. The global market, which surpassed $885 billion in 2025, is projected to reach $1.2 trillion by 2035. This growth is attracting significant attention from private equity firms, which have been instrumental in consolidating and modernizing this traditionally fragmented industry.

Private equity's 'buy-and-build' playbook—acquiring a platform company and growing it through strategic acquisitions and operational enhancements—has been deployed with great success in this space. EQT's investment in Azelis, itself a secondary buyout from another PE firm, highlights the long-term role of private capital in shaping the industry's leaders.

As Azelis moves forward, it does so in a landscape profoundly shaped by the very forces that built it into a global powerhouse. Its ability to leverage its scale, digital infrastructure, and sustainability credentials will be critical as it navigates competitive pressures and market volatility on its own.